secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuo Therapeutics, Inc. (AURX)
CIK:        0001091596
Form:       8-K
Filed at:   2024-06-11T23:59:59+00:00
Accession:  0001437749-24-019961
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nuo Therapeutics dismisses auditor Marcum, engages MaloneBailey; cites material weaknesses
--------------------------------------------------------------------------------

- Effective June 7, 2024, dismissed Marcum LLP as independent auditor; engaged MaloneBailey, LLP for FY 2024.
- Marcum's reports for FY2023 and FY2022 included going-concern explanatory paragraphs.
- Identified material weaknesses: insufficient accounting staff and lack of effective internal control over financial reporting.
- No disagreements with Marcum on accounting principles or audit scope prior to dismissal.
- Marcum's letter to SEC agreeing with disclosures filed as Exhibit 16.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1091596/000143774924019961/0001437749-24-019961-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1091596/000143774924019961/aurx20240606_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-019961

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer